CapitalVue News -- May 14 -- Sichuan Kelun Pharmaceutical, one of the largest manufacturers of intravenous solutions (IV solutions) in the world, plans to issue 60 million A-shares or 25 percent of its enlarged share capital in its initial public offering (IPO), reports China Securities Journal, citing the company's prospectus.
